IL67822A - Nasal pharmaceutical composition comprising an ergopeptide and a xanthine - Google Patents

Nasal pharmaceutical composition comprising an ergopeptide and a xanthine

Info

Publication number
IL67822A
IL67822A IL67822A IL6782283A IL67822A IL 67822 A IL67822 A IL 67822A IL 67822 A IL67822 A IL 67822A IL 6782283 A IL6782283 A IL 6782283A IL 67822 A IL67822 A IL 67822A
Authority
IL
Israel
Prior art keywords
ergopeptide
xanthine
pharmaceutical composition
nasal pharmaceutical
nasal
Prior art date
Application number
IL67822A
Other languages
English (en)
Other versions
IL67822A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL67822A0 publication Critical patent/IL67822A0/xx
Publication of IL67822A publication Critical patent/IL67822A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL67822A 1982-02-01 1983-02-01 Nasal pharmaceutical composition comprising an ergopeptide and a xanthine IL67822A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (2)

Publication Number Publication Date
IL67822A0 IL67822A0 (en) 1983-06-15
IL67822A true IL67822A (en) 1988-02-29

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
IL67822A IL67822A (en) 1982-02-01 1983-02-01 Nasal pharmaceutical composition comprising an ergopeptide and a xanthine

Country Status (27)

Country Link
JP (1) JPS58134017A (pt)
AT (1) AT385656B (pt)
AU (1) AU565613B2 (pt)
BE (1) BE895750A (pt)
CA (1) CA1197783A (pt)
CH (1) CH653555A5 (pt)
DE (1) DE3302949A1 (pt)
DK (1) DK164771C (pt)
ES (1) ES519450A0 (pt)
FI (1) FI81258C (pt)
FR (1) FR2539994B1 (pt)
GR (1) GR81320B (pt)
HK (1) HK59989A (pt)
HU (1) HU191512B (pt)
IE (1) IE54532B1 (pt)
IL (1) IL67822A (pt)
IT (1) IT1197558B (pt)
KE (1) KE3888A (pt)
LU (1) LU84613A1 (pt)
MY (1) MY8700766A (pt)
NL (1) NL192325C (pt)
NZ (1) NZ203117A (pt)
PH (1) PH22198A (pt)
PT (1) PT76166B (pt)
SE (1) SE454402B (pt)
SG (1) SG34389G (pt)
ZA (1) ZA83673B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
KR20200118032A (ko) * 2018-01-05 2020-10-14 임펠 뉴로파마 인코포레이티드 정밀 후각기관 장치에 의한 디하이드로에르고타민의 비강내 전달

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
ES8502865A1 (es) 1985-02-01
DK164771B (da) 1992-08-17
JPH0253406B2 (pt) 1990-11-16
NL8300325A (nl) 1983-09-01
ES519450A0 (es) 1985-02-01
SE454402B (sv) 1988-05-02
BE895750A (fr) 1983-08-01
PT76166A (en) 1983-02-01
ATA30383A (de) 1987-10-15
FI81258B (fi) 1990-06-29
DK38183A (da) 1983-08-02
IL67822A0 (en) 1983-06-15
FR2539994B1 (fr) 1986-10-10
AT385656B (de) 1988-05-10
GR81320B (pt) 1984-12-11
AU1085083A (en) 1983-08-11
CA1197783A (en) 1985-12-10
IE54532B1 (en) 1989-11-08
LU84613A1 (fr) 1983-09-08
MY8700766A (en) 1987-12-31
IE830187L (en) 1983-08-01
SE8300495L (sv) 1983-08-02
DE3302949A1 (de) 1983-08-11
FI830245L (fi) 1983-08-02
NZ203117A (en) 1986-12-05
HK59989A (en) 1989-08-04
FI830245A0 (fi) 1983-01-25
DE3302949C2 (pt) 1992-05-21
DK164771C (da) 1992-12-28
SE8300495D0 (sv) 1983-01-31
CH653555A5 (de) 1986-01-15
PH22198A (en) 1988-06-28
HU191512B (en) 1987-02-27
NL192325B (nl) 1997-02-03
FR2539994A1 (fr) 1984-08-03
IT8347646A0 (it) 1983-02-01
IT1197558B (it) 1988-12-06
SG34389G (en) 1989-09-22
FI81258C (fi) 1990-10-10
KE3888A (en) 1989-09-01
AU565613B2 (en) 1987-09-24
JPS58134017A (ja) 1983-08-10
NL192325C (nl) 1997-06-04
DK38183D0 (da) 1983-01-31

Similar Documents

Publication Publication Date Title
DE3372705D1 (en) Pharmaceutical composition and its use
GB2144997B (en) Dosage inhalator
DE3573729D1 (en) Medicament inhalation device
GB8325529D0 (en) Medicinal forms
IL64847A (en) Immunomodulating phosphorylsubstituted muramylpeptide analogues and pharmaceutical compositions containing them
GB8411259D0 (en) Medicinal agent
IL69892A0 (en) Pharmaceutical compositions comprising calcitonin
GB2116564B (en) Calcitonin derivatives
ZA864164B (en) Nasal pharmaceutical compositions
PH20168A (en) 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions
DE3373623D1 (en) Pharmaceutical combination composition and associated method
NZ198862A (en) Enkephalin derivatives and pharmaceutical compositions
ZA83130B (en) A pharmaceutical composition
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
IL70379A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
IL67822A (en) Nasal pharmaceutical composition comprising an ergopeptide and a xanthine
GB8525673D0 (en) Pharmaceutical agent
GB8302374D0 (en) Nasal pharmaceutical compositions
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
IL68668A0 (en) Piperidinoquinazolines and pharmaceutical compositions containing them
GB2124628B (en) 6-oxo-tetrahydropyran derivatives and cyanomethyl-azetidinones
GB2116563B (en) Calcitonin derivatives
GB8509165D0 (en) Pharmaceutical agent
GB8305029D0 (en) Pharmaceutical and dietary composition
ZA839200B (en) Pharmaceutical compositions comprising a hydrogenated ergotalkaloid and heparin

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
EXP Patent expired